Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Melanoma is one of the most therapy‐resistant cancers. Activating mutations in BRAF and NRAS are the source of extracellular signal regulated protein kinase (ERK) pathway activation. We show that melanoma cell lines, originating in different metastatic sites, with BRAF or NRAS mutations, in addition to active mitogen activated protein kinase (MAPK)–ERK, also have highly activated stress activated protein kinase (SAPK)‐p38. This is in direct contrast to carcinoma cells in which the activity of the two kinases appears to be mutually exclusive; high level of p38 activity inhibits, through a negative feedback, ERK activity and prevents tumorigenesis. Melanomas are insensitive to ERK inhibition by p38 and utilize p38‐signaling pathway for migration and growth in vivo. We found a positive functional loop linking the high ERK activity to surface expression of αVβ3‐integrin. This integrin, by interacting with vitronectin, induces p38 activity and increases IL‐8 production, enhancing cell migration. Because the negative loop from p38 to ERK is lost, the two kinases can remain simultaneously activated. Inhibition of ERK and p38 activities is more effective in blocking in vivo growth than inhibition of each kinase individually. Future therapies might have to consider targeting of both pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371 · cited 4×
“between BRAF mutation and persistent activation of the ERK pathway (Gray-Schopfer et al., 2007).”
BackgroundInfluentialProtein phosphatase 2A interacts with and directly dephosphorylates RelA
Yang, J., Fan, G.-H., Wadzinski, B. E., Sakurai, H., & Richmond, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106103200 · Cited by 130 · cited 2×
“It is still possible that, as previously shown (Yang et al., 2001) PP2A activity, and not expression, is down regulated in melanomas contributing to loss of ERK inhibition by p38.”
Background
Cited by
p38MAPK: stress responses from molecular mechanisms to therapeutics
Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F., & Burchill, S. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.06.005 · Cited by 691
Corazzari, M., Rapino, F., Ciccosanti, F., Giglio, P., Antonioli, M., Conti, B., Fimia, G. M., Lovat, P. E., & Piacentini, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.183 · Cited by 162
“Published data demonstrate that melanoma cells harbouring hyperactivating mutations in BRAF or NRAS display increased activation of the stress-activated protein kinase (SAPK)p38.(42) Moreover, it has also been reported that active p38 in cancer cells is able to induce an ER stress response to coordinate cell survival…”
BackgroundZhang, Y.-Y., Wu, J.-W., & Wang, Z.-X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203786 · Cited by 63
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
Raymond, J. H., Aktary, Z., Larue, L., & Delmas, V. (2022) · Cancers · doi:10.3390/cancers14030706 · Cited by 20
UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPK
Muthusamy, V., & Piva, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140817029 · Cited by 11
“This inhibition was overcome by the addition of exogenous IL8, which confirms that this cytokine is downstream of the p38 MAPK pathway governing the migration of melanoma cells [10].”
BackgroundInfluential
Metadata
- Authors
- Estrada, Y., Dong, J., & Ossowski, L.
- Venue
- Pigment Cell & Melanoma Research
- Publisher
- Wiley
- Published
- 2009-01-16
- Volume
- 22
- Issue
- 1
- Pages
- 66-76
- ISSN
- 1755-1471 (ISSN-L)
- 1755-148X
- OpenAlex
- W2147723228
- Cited by
- 84
- References
- 2
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. https://app.cochat.ai/papers/10.1111/j.1755-148x.2008.00520.x
- The paper
- Estrada, Y., Dong, J., & Ossowski, L. (2009). Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell & Melanoma Research. https://doi.org/10.1111/j.1755-148x.2008.00520.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.